Omada Health (NASDAQ:OMDA) CAO Sells 2,083 Shares

Omada Health, Inc. (NASDAQ:OMDAGet Free Report) CAO Craig Gracey sold 2,083 shares of the company’s stock in a transaction dated Wednesday, June 24th. The shares were sold at an average price of $19.01, for a total transaction of $39,597.83. Following the completion of the sale, the chief accounting officer directly owned 5,025 shares in the company, valued at $95,525.25. This trade represents a 29.31% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Craig Gracey also recently made the following trade(s):

  • On Monday, June 22nd, Craig Gracey sold 2,083 shares of Omada Health stock. The stock was sold at an average price of $18.00, for a total value of $37,494.00.
  • On Friday, June 12th, Craig Gracey sold 6,894 shares of Omada Health stock. The shares were sold at an average price of $17.42, for a total value of $120,093.48.

Omada Health Trading Up 10.5%

Shares of NASDAQ OMDA traded up $1.99 during trading on Friday, reaching $20.89. The company had a trading volume of 3,310,497 shares, compared to its average volume of 946,807. Omada Health, Inc. has a twelve month low of $10.28 and a twelve month high of $26.92. The stock has a market capitalization of $1.24 billion and a PE ratio of -77.37. The stock has a 50-day moving average price of $16.51 and a two-hundred day moving average price of $14.85.

Omada Health (NASDAQ:OMDAGet Free Report) last posted its quarterly earnings data on Thursday, May 7th. The company reported ($0.05) EPS for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.03. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%.The business had revenue of $78.05 million for the quarter. On average, sell-side analysts predict that Omada Health, Inc. will post -0.01 EPS for the current year.

Institutional Trading of Omada Health

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Quarry LP purchased a new position in Omada Health in the fourth quarter valued at approximately $29,000. TD Waterhouse Canada Inc. purchased a new position in shares of Omada Health in the 4th quarter valued at $32,000. Raymond James Financial Inc. acquired a new position in shares of Omada Health during the 2nd quarter valued at $32,000. Inlight Wealth Management LLC acquired a new stake in Omada Health in the 4th quarter valued at $45,000. Finally, Strs Ohio raised its position in Omada Health by 151.0% in the fourth quarter. Strs Ohio now owns 4,267 shares of the company’s stock valued at $67,000 after purchasing an additional 2,567 shares during the period.

Analyst Ratings Changes

A number of analysts recently issued reports on the stock. Barclays raised their target price on shares of Omada Health from $18.00 to $20.00 and gave the stock an “overweight” rating in a research report on Friday, May 8th. The Goldman Sachs Group reissued a “buy” rating on shares of Omada Health in a research note on Friday, May 8th. Weiss Ratings restated a “sell (e+)” rating on shares of Omada Health in a report on Thursday, June 4th. Citigroup reissued an “outperform” rating on shares of Omada Health in a research note on Friday, May 8th. Finally, Citizens Jmp increased their price objective on shares of Omada Health from $18.00 to $21.00 and gave the stock a “market outperform” rating in a report on Friday, May 8th. Ten analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Omada Health presently has a consensus rating of “Moderate Buy” and an average target price of $22.91.

Check Out Our Latest Research Report on OMDA

About Omada Health

(Get Free Report)

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.

Further Reading

Insider Buying and Selling by Quarter for Omada Health (NASDAQ:OMDA)

Receive News & Ratings for Omada Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omada Health and related companies with MarketBeat.com's FREE daily email newsletter.